Insider · CIK 0001930862
Michelle Gilson
cfoofficer
Files at ACLX (Arcellx, Inc.). First filing Nov 12, 2024, latest May 28, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 5
$0 bought, $4.4M sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 47Moderate | Arcellx, Inc. | $785k 12,235 shares | -38% | - | |
| 47Moderate | Arcellx, Inc. | $1.4M 18,009 shares | -65% | - | |
| 55Moderate | Arcellx, Inc. | $831k 10,604 shares | -27% | - | |
| 26Weak | Arcellx, Inc. | $157k 1,761 shares | -100% | - | |
| 40Moderate | Arcellx, Inc. | $1.2M 12,354 shares | -88% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 23, 2025 | ACLX Arcellx, Inc. | MOption exercise Common Stock | +22,429 | $0.00 | $0 | 32,011 | May 28, 2025 |
| May 27, 2025 | ACLX Arcellx, Inc. | SOpen-market sale Common Stock | -3,786 | $63.62 | $241k | 28,225 | May 28, 2025 |
| May 27, 2025 | ACLX Arcellx, Inc. | SOpen-market sale Common Stock | -8,449 | $64.38 | $544k | 19,776 | May 28, 2025 |
| May 23, 2025 | ACLX Arcellx, Inc. | MOption exercise Restricted Stock Unitsderivative | -22,429 | $0.00 | $0 | 0 | May 28, 2025 |
| Jan 3, 2025 | ACLX Arcellx, Inc. | MOption exercise Common Stock10b5-1 | +15,339 | $0.00 | $0 | 38,834 | Jan 10, 2025 |
| Jan 7, 2025 | ACLX Arcellx, Inc. | SOpen-market sale Common Stock10b5-1 | -3,128 | $74.43 | $233k | 24,463 | Jan 10, 2025 |
| Jan 7, 2025 | ACLX Arcellx, Inc. | SOpen-market sale Common Stock10b5-1 | -1,546 | $75.23 | $116k | 22,917 | Jan 10, 2025 |
| Jan 7, 2025 | ACLX Arcellx, Inc. | SOpen-market sale Common Stock10b5-1 | -2,251 | $76.64 | $173k | 20,666 | Jan 10, 2025 |
| Jan 7, 2025 | ACLX Arcellx, Inc. | SOpen-market sale Common Stock10b5-1 | -2,327 | $77.06 | $179k | 18,339 | Jan 10, 2025 |
| Jan 7, 2025 | ACLX Arcellx, Inc. | SOpen-market sale Common Stock10b5-1 | -4,760 | $75.53 | $360k | 13,579 | Jan 10, 2025 |
| Jan 8, 2025 | ACLX Arcellx, Inc. | SOpen-market sale Common Stock10b5-1 | -3,997 | $73.69 | $295k | 9,582 | Jan 10, 2025 |
| Jan 3, 2025 | ACLX Arcellx, Inc. | MOption exercise Restricted Stock Unitderivative10b5-1 | -15,339 | $0.00 | $0 | 15,340 | Jan 10, 2025 |
| Jan 2, 2025 | ACLX Arcellx, Inc. | MOption exercise Common Stock | +20,495 | $0.00 | $0 | 23,495 | Jan 6, 2025 |
| Jan 3, 2025 | ACLX Arcellx, Inc. | MOption exercise Common Stock | +15,339 | $0.00 | $0 | 38,834 | Jan 6, 2025 |
| Jan 3, 2025 | ACLX Arcellx, Inc. | SOpen-market sale Common Stock | -5,502 | $79.55 | $438k | 33,332 | Jan 6, 2025 |
| Jan 6, 2025 | ACLX Arcellx, Inc. | SOpen-market sale Common Stock | -5,102 | $77.17 | $394k | 28,230 | Jan 6, 2025 |
| Jan 2, 2025 | ACLX Arcellx, Inc. | MOption exercise Restricted Stock Unitderivative | -20,495 | $0.00 | $0 | 40,992 | Jan 6, 2025 |
| Jan 3, 2025 | ACLX Arcellx, Inc. | MOption exercise Restricted Stock Unitderivative | -15,339 | $0.00 | $0 | 15,340 | Jan 6, 2025 |
| Jan 6, 2025 | ACLX Arcellx, Inc. | AGrant or award Restricted Stock Unitderivative | +82,120 | $0.00 | $0 | 82,120 | Jan 6, 2025 |
| Nov 15, 2024 | ACLX Arcellx, Inc. | SOpen-market sale Common Stock10b5-1 | -1,061 | $87.89 | $93k | 700 | Nov 19, 2024 |
| Nov 15, 2024 | ACLX Arcellx, Inc. | SOpen-market sale Common Stock10b5-1 | -500 | $89.17 | $45k | 200 | Nov 19, 2024 |
| Nov 15, 2024 | ACLX Arcellx, Inc. | SOpen-market sale Common Stock10b5-1 | -100 | $91.67 | $9,167 | 100 | Nov 19, 2024 |
| Nov 15, 2024 | ACLX Arcellx, Inc. | SOpen-market sale Common Stock10b5-1 | -100 | $95.00 | $9,500 | 0 | Nov 19, 2024 |
| Nov 19, 2024 | ACLX Arcellx, Inc. | MOption exercise Common Stock10b5-1 | +3,000 | $8.66 | $26k | 3,000 | Nov 19, 2024 |
| Nov 19, 2024 | ACLX Arcellx, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -3,000 | $0.00 | $0 | 78,315 | Nov 19, 2024 |
| Nov 8, 2024 | ACLX Arcellx, Inc. | MOption exercise Common Stock10b5-1 | +7,200 | $8.66 | $62k | 14,115 | Nov 12, 2024 |
| Nov 8, 2024 | ACLX Arcellx, Inc. | SOpen-market sale Common Stock10b5-1 | -9,700 | $100.26 | $973k | 4,415 | Nov 12, 2024 |
| Nov 8, 2024 | ACLX Arcellx, Inc. | SOpen-market sale Common Stock10b5-1 | -1,853 | $101.27 | $188k | 2,562 | Nov 12, 2024 |
| Nov 8, 2024 | ACLX Arcellx, Inc. | SOpen-market sale Common Stock10b5-1 | -801 | $102.33 | $82k | 1,761 | Nov 12, 2024 |
| Nov 8, 2024 | ACLX Arcellx, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -7,200 | $0.00 | $0 | 81,315 | Nov 12, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.